Status:
COMPLETED
Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries
Lead Sponsor:
Ahalia Foundation Eye Hospital
Conditions:
Diabetic Retinopathy
Macular Traction Retinal Detachment
Eligibility:
All Genders
18-99 years
Brief Summary
The goal of this observational study is to learn about safety and results of peroperative and intraoperative intravenous Tranexamic acid for diabetic macular tractional detachment eye surgeries . The ...
Detailed Description
all Patients who agreed and gave informed consent forsurgery as well as to be included in study were included Patients injected INTRAVENOUS TRANEXAMIC ACID 500 mg diluted to 10 ml with normal saline ...
Eligibility Criteria
Inclusion
- Eyes of Diabetic patients having Macular Tractional Retinal detachment confirmed on Indirect Ophthalmoscope or B scan when associated with Vitreous hemorrhage or Optical Coherence Tomography
Exclusion
- Pregnancy, lactation, Oral Contraceptive use, within 6 months thromboembolic disease ,Underlying cardiac arrhythmia where anticoagulation is indicated ,Seizures Severe liver disease,previous history of variceal bleeding ,Allergic history to Tranexamic acid
- Ophthalmic exclusion criteria Previous vitreoretinal surgery Combination of tractional and rhegmatogenous retinal detachment Coexisting macular hole Macular dystrophies Arterial or venous occlusions Age related macular degeneration Extensive macular scarring Posterior segment inflammation
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06560073
Start Date
January 15 2021
End Date
October 31 2022
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahaliafoundation Eye Hospital
Palakkad, Kerala, India, 678557